Literature DB >> 7827242

Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men.

I Thune1, E Lund.   

Abstract

The associations between recreational and occupational physical activity and the subsequent risk of prostate and testicular cancer were examined in a population-based cohort study of 53,242 men in Norway. Age at study entry was 19 to 50 years. Information on physical activity was based on questionnaire responses and a brief clinical examination. A total of 220 prostate and 47 testicular cancer cases were recorded in the Cancer Registry of Norway during a mean follow-up time of 16.3 years. We found a nonsignificant, reduced, adjusted relative risk (RR) of prostate cancer with increased level of physical activity at work and among those men with the greatest recreational physical activity. When occupational and recreational physical activity were combined, a reduced adjusted risk of prostate cancer was observed among men who walked during occupational hours and performed either moderate recreational activity (RR = 0.61, 95 percent confidence interval [CI] = 0.36 to 1.01) or regular recreational training (RR = 0.45, CI = 0.20 to 1.01) relative to sedentary men (test for trend, P = 0.03). Physically active men who were older than 60 years of age at diagnosis showed a reduced adjusted RR of borderline significance, while no association was observed for younger men. No evidence was found for any association between physical activity and testicular cancer regardless of physical activity at work and recreation.

Entities:  

Mesh:

Year:  1994        PMID: 7827242     DOI: 10.1007/bf01831383

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  38 in total

1.  Physical activity, physical fitness and risk of myocardial infarction.

Authors:  L Wilhelmsen; G Tibblin; M Aurell; J Bjure; B Ekström-Jodal; G Grimby
Journal:  Adv Cardiol       Date:  1976

2.  College athletics, body size, and cancer mortality.

Authors:  A P Polednak
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

3.  Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise.

Authors:  H Adlercreutz; M Härkönen; K Kuoppasalmi; H Näveri; I Huhtaniemi; H Tikkanen; K Remes; A Dessypris; J Karvonen
Journal:  Int J Sports Med       Date:  1986-06       Impact factor: 3.118

Review 4.  Risk factors for prostate and testicular cancer.

Authors:  P Boyle; D G Zaridze
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

5.  The epidemiology of plasma testosterone levels in middle-aged men.

Authors:  W S Dai; L H Kuller; R E LaPorte; J P Gutai; L Falvo-Gerard; A Caggiula
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

6.  The cardiovascular disease study in Norwegian counties. Results from first screening.

Authors:  K Bjartveit; O P Foss; T Gjervig
Journal:  Acta Med Scand Suppl       Date:  1983

7.  Weight loss in amateur wrestlers and its effect on serum testosterone levels.

Authors:  R H Strauss; R R Lanese; W B Malarkey
Journal:  JAMA       Date:  1985-12-20       Impact factor: 56.272

8.  Hormonal changes in serum in young men during prolonged physical strain.

Authors:  A Aakvaag; T Sand; P K Opstad; F Fonnum
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1978-10-20

9.  Hormonal risk factors in testicular cancer. A case-control study.

Authors:  A R Moss; D Osmond; P Bacchetti; F M Torti; V Gurgin
Journal:  Am J Epidemiol       Date:  1986-07       Impact factor: 4.897

10.  Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study.

Authors:  I Holme; A Helgeland; I Hjermann; P Leren; P G Lund-Larsen
Journal:  Acta Med Scand       Date:  1981
View more
  24 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 2.  Prostate cancer: 3. Individual risk factors.

Authors:  R P Gallagher; N Fleshner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 3.  [Epidemiological evidence for preventing prostate cancer by physical activity].

Authors:  Hans-Christian Heitkamp; Ivan Jelas
Journal:  Wien Med Wochenschr       Date:  2012-10-12

Review 4.  Is exercise beneficial in the prevention of prostate cancer?

Authors:  S A Oliveria; I M Lee
Journal:  Sports Med       Date:  1997-05       Impact factor: 11.136

Review 5.  Physical Activity and Prostate Cancer: An Updated Review.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2017-06       Impact factor: 11.136

6.  Sedentary behavior and prostate cancer risk in the NIH-AARP Diet and Health Study.

Authors:  Brigid M Lynch; Christine M Friedenreich; Karen A Kopciuk; Albert R Hollenbeck; Steven C Moore; Charles E Matthews
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-13       Impact factor: 4.254

Review 7.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 8.  A systematic review and meta-analysis of the relationship between body size and testicular cancer.

Authors:  C C Lerro; K A McGlynn; M B Cook
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

9.  Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis.

Authors:  Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

10.  Occupational physical activity and risk for prostate cancer in a nationwide cohort study in Sweden.

Authors:  A Norman; T Moradi; G Gridley; M Dosemeci; B Rydh; O Nyrén; A Wolk
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.